Test Bank For Pharmacology and the Nursing
Process 10th Edition By Linda Lilley 2023
, Test Bank For Pharmacology and the Nursing
Process 10th Edition By Linda Lilley 2023
Table of Contents
Chapter 01: The Nursing Process and Drug Therapy ............................................................................................... 4
Chapter 02: Pharmacologic Principles ..................................................................................................................... 8
Chapter 03: Lifespan Considerations ..................................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations ....................................................................................... 20
Chapter 05: Medication Errors: Preventing and Responding ................................................................................. 25
Chapter 06: Patient Education and Drug Therapy .................................................................................................. 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ......................................................... 35
Chapter 08: Gene Therapy and Pharmacogenomics ............................................................................................... 41
Chapter 09: Photo Atlas of Drug Administration ................................................................................................... 47
Chapter 10: Analgesic Drugs .................................................................................................................................. 60
Chapter 11: General and Local Anesthetics............................................................................................................ 69
Chapter 12: Central Nervous System Depressants and MuscleRelaxants............................................................. 73
Chapter 13: Central Nervous System Stimulants and RelatedDrugs...................................................................... 78
Chapter 14: Antiepileptic Drugs ............................................................................................................................. 82
Chapter 15: Antiparkinson Drugs ........................................................................................................................... 87
Chapter 16: Psychotherapeutic Drugs .................................................................................................................... 92
Chapter 17: Substance Use Disorder ...................................................................................................................... 98
Chapter 18: Adrenergic Drugs .............................................................................................................................. 102
Chapter 19: Adrenergic-Blocking Drugs .............................................................................................................. 106
Chapter 20: Cholinergic Drugs ............................................................................................................................. 111
Chapter 21: Cholinergic-Blocking Drugs ............................................................................................................. 116
Chapter 22: Antihypertensive Drugs .................................................................................................................... 121
Chapter 23: Antianginal Drugs ............................................................................................................................. 128
Chapter 24: Heart Failure Drugs........................................................................................................................... 136
Chapter 25: Antidysrhythmic Drugs ..................................................................................................................... 144
Chapter 26: Coagulation Modifier Drugs ............................................................................................................. 152
Chapter 27: Antilipemic Drugs ............................................................................................................................. 160
Chapter 28: Diuretic Drugs................................................................................................................................... 167
Chapter 29: Fluids and Electrolytes ...................................................................................................................... 173
Chapter 30: Pituitary Drugs .................................................................................................................................. 178
Chapter 31: Thyroid and Antithyroid Drugs......................................................................................................... 182
Chapter 32: Diabetes Drugs .................................................................................................................................. 187
Chapter 33: Adrenal Drugs ................................................................................................................................... 195
Chapter 34: Women’s Health Drugs ..................................................................................................................... 199
Want to earn $1.236
Distribution of this document is illegal extra per year?
,Chapter 35: Men’s Health Drugs .......................................................................................................................... 206
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants...................................................... 210
Chapter 37: Respiratory Drugs ............................................................................................................................. 215
Chapter 38: Antibiotics Part 1 .............................................................................................................................. 220
Chapter 39: Antibiotics Part 2 .............................................................................................................................. 226
Chapter 40: Antiviral Drugs ................................................................................................................................. 231
Chapter 41: Antitubercular Drugs ........................................................................................................................ 236
Chapter 42: Antifungal Drugs .............................................................................................................................. 240
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ...................................................................... 245
Chapter 44: Anti-inflammatory and Antigout Drugs ............................................................................................ 249
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle-SpecificDrugs ............................... 254
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–NonspecificDrugs andMiscellaneous Drugs.................... 260
Chapter 47: Biologic Response–Modifying and AntirheumaticDrugs ................................................................. 264
Chapter 48: Immunosuppressant Drugs................................................................................................................ 268
Chapter 50: Acid-Controlling Drugs .................................................................................................................... 277
Chapter 51: Bowel Disorder Drugs ...................................................................................................................... 283
Chapter 52: Antiemetic and Antinausea Drugs .................................................................................................... 290
Chapter 53: Vitamins and Minerals ...................................................................................................................... 295
Chapter 54: Anemia Drugs ................................................................................................................................... 301
Chapter 55: Nutritional Supplements ................................................................................................................... 307
Chapter 56: Dermatologic Drugs .......................................................................................................................... 311
Chapter 57: Ophthalmic Drugs ............................................................................................................................. 317
Chapter 58: Otic Drugs ......................................................................................................................................... 321
Want to earn $1.236
Distribution of this document is illegal extra per year?
, Chapter 01: The Nursing Process and Drug Therapy
Lilley: Pharmacology and the Nursing Process, 10th Edition
MULTIPLE CHOICE
1. The nurse is developing a human needs statement for a patient who has a new diagnosis of
heart failure. Identification of human needs statements occur with which of these activities?
a. Collection of patient data
b. Administering interventions
c. Deciding on patient outcomes
d. Documenting the patient‘s behavior
ANS: A
Identification of human needs occurs with the collection of patient data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Human Needs Statement
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. The patient is to receive oral guaifenesin twice a day. Today, the nurse was busy and gave the
medication 2 hours after the scheduled dose was due. What type of problem does this
represent?
a. ―Right time‖
b. ―Right dose‖
c. ―Right route‖
d. ―Right medication‖
ANS: A
―Right time‖ is correct because the medication was given more than 30 minutes after the
scheduled dose was due. ―Dose‖ is incorrect because the dose is not related to the time the
medication administration is scheduled. ―Route‖ is incorrect because the route is not affected.
―Medication‖ is incorrect because the medication ordered will not change.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
3. The nurse has been monitoring the patient‘s progress on a new drug regimen since the first
dose and documenting the patient‘s therapeutic response to the medication. Which phase of
the nursing process do these actions illustrate?
a. Human needs statement
b. Planning
c. Implementation
d. Evaluation
ANS: D
Monitoring the patient‘s progress, including the patient‘s response to the medication, is part of
the evaluation phase. Planning, implementation, and human needs statement are not illustrated
by this example.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Evaluation
Want to earn $1.236
Distribution of this document is illegal extra per year?
Process 10th Edition By Linda Lilley 2023
, Test Bank For Pharmacology and the Nursing
Process 10th Edition By Linda Lilley 2023
Table of Contents
Chapter 01: The Nursing Process and Drug Therapy ............................................................................................... 4
Chapter 02: Pharmacologic Principles ..................................................................................................................... 8
Chapter 03: Lifespan Considerations ..................................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations ....................................................................................... 20
Chapter 05: Medication Errors: Preventing and Responding ................................................................................. 25
Chapter 06: Patient Education and Drug Therapy .................................................................................................. 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ......................................................... 35
Chapter 08: Gene Therapy and Pharmacogenomics ............................................................................................... 41
Chapter 09: Photo Atlas of Drug Administration ................................................................................................... 47
Chapter 10: Analgesic Drugs .................................................................................................................................. 60
Chapter 11: General and Local Anesthetics............................................................................................................ 69
Chapter 12: Central Nervous System Depressants and MuscleRelaxants............................................................. 73
Chapter 13: Central Nervous System Stimulants and RelatedDrugs...................................................................... 78
Chapter 14: Antiepileptic Drugs ............................................................................................................................. 82
Chapter 15: Antiparkinson Drugs ........................................................................................................................... 87
Chapter 16: Psychotherapeutic Drugs .................................................................................................................... 92
Chapter 17: Substance Use Disorder ...................................................................................................................... 98
Chapter 18: Adrenergic Drugs .............................................................................................................................. 102
Chapter 19: Adrenergic-Blocking Drugs .............................................................................................................. 106
Chapter 20: Cholinergic Drugs ............................................................................................................................. 111
Chapter 21: Cholinergic-Blocking Drugs ............................................................................................................. 116
Chapter 22: Antihypertensive Drugs .................................................................................................................... 121
Chapter 23: Antianginal Drugs ............................................................................................................................. 128
Chapter 24: Heart Failure Drugs........................................................................................................................... 136
Chapter 25: Antidysrhythmic Drugs ..................................................................................................................... 144
Chapter 26: Coagulation Modifier Drugs ............................................................................................................. 152
Chapter 27: Antilipemic Drugs ............................................................................................................................. 160
Chapter 28: Diuretic Drugs................................................................................................................................... 167
Chapter 29: Fluids and Electrolytes ...................................................................................................................... 173
Chapter 30: Pituitary Drugs .................................................................................................................................. 178
Chapter 31: Thyroid and Antithyroid Drugs......................................................................................................... 182
Chapter 32: Diabetes Drugs .................................................................................................................................. 187
Chapter 33: Adrenal Drugs ................................................................................................................................... 195
Chapter 34: Women’s Health Drugs ..................................................................................................................... 199
Want to earn $1.236
Distribution of this document is illegal extra per year?
,Chapter 35: Men’s Health Drugs .......................................................................................................................... 206
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants...................................................... 210
Chapter 37: Respiratory Drugs ............................................................................................................................. 215
Chapter 38: Antibiotics Part 1 .............................................................................................................................. 220
Chapter 39: Antibiotics Part 2 .............................................................................................................................. 226
Chapter 40: Antiviral Drugs ................................................................................................................................. 231
Chapter 41: Antitubercular Drugs ........................................................................................................................ 236
Chapter 42: Antifungal Drugs .............................................................................................................................. 240
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ...................................................................... 245
Chapter 44: Anti-inflammatory and Antigout Drugs ............................................................................................ 249
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle-SpecificDrugs ............................... 254
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–NonspecificDrugs andMiscellaneous Drugs.................... 260
Chapter 47: Biologic Response–Modifying and AntirheumaticDrugs ................................................................. 264
Chapter 48: Immunosuppressant Drugs................................................................................................................ 268
Chapter 50: Acid-Controlling Drugs .................................................................................................................... 277
Chapter 51: Bowel Disorder Drugs ...................................................................................................................... 283
Chapter 52: Antiemetic and Antinausea Drugs .................................................................................................... 290
Chapter 53: Vitamins and Minerals ...................................................................................................................... 295
Chapter 54: Anemia Drugs ................................................................................................................................... 301
Chapter 55: Nutritional Supplements ................................................................................................................... 307
Chapter 56: Dermatologic Drugs .......................................................................................................................... 311
Chapter 57: Ophthalmic Drugs ............................................................................................................................. 317
Chapter 58: Otic Drugs ......................................................................................................................................... 321
Want to earn $1.236
Distribution of this document is illegal extra per year?
, Chapter 01: The Nursing Process and Drug Therapy
Lilley: Pharmacology and the Nursing Process, 10th Edition
MULTIPLE CHOICE
1. The nurse is developing a human needs statement for a patient who has a new diagnosis of
heart failure. Identification of human needs statements occur with which of these activities?
a. Collection of patient data
b. Administering interventions
c. Deciding on patient outcomes
d. Documenting the patient‘s behavior
ANS: A
Identification of human needs occurs with the collection of patient data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Human Needs Statement
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. The patient is to receive oral guaifenesin twice a day. Today, the nurse was busy and gave the
medication 2 hours after the scheduled dose was due. What type of problem does this
represent?
a. ―Right time‖
b. ―Right dose‖
c. ―Right route‖
d. ―Right medication‖
ANS: A
―Right time‖ is correct because the medication was given more than 30 minutes after the
scheduled dose was due. ―Dose‖ is incorrect because the dose is not related to the time the
medication administration is scheduled. ―Route‖ is incorrect because the route is not affected.
―Medication‖ is incorrect because the medication ordered will not change.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
3. The nurse has been monitoring the patient‘s progress on a new drug regimen since the first
dose and documenting the patient‘s therapeutic response to the medication. Which phase of
the nursing process do these actions illustrate?
a. Human needs statement
b. Planning
c. Implementation
d. Evaluation
ANS: D
Monitoring the patient‘s progress, including the patient‘s response to the medication, is part of
the evaluation phase. Planning, implementation, and human needs statement are not illustrated
by this example.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Evaluation
Want to earn $1.236
Distribution of this document is illegal extra per year?
